Bio Sb, Inc.

bio sb performs r&d, production and marketing of monoclonal and polyclonal antibodies, cancer detection systems, dna probes, pcr kits and equipment and reagents for liquid cytology. bio sb helps institutions implement state-of-the-art cancer diagnostics technologies which include: * immunohistochemistry (ihc) to determine cancer-related protein expression * chromogenic in situ hybridization (cish), a practical, cost-effective, and valid alternative to fluorescent in situ hybridization (fish) * pcr (polymerase chain reaction) to analyze disease-related nucleic acids * liquid cytology, an inexpensive alternative to other liquid-based cytology (lbc) tests for cervical cancer screening in addition to providing its customers with equipment, reagents, and kits, bio sb also provides training and continual assistance to new and existing laboratories. bio sb's skill and knowledge in immunopathology, lmmunology and molecular biology offer the total solution for both cell and tissue stai